世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のMRIシステム市場予測 2018-2026年

GLOBAL MRI SYSTEM MARKET FORECAST 2018-2026

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2018年6月US$2,500
シングルユーザライセンス
165

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは世界のMRIシステム市場を分析・予測したInkwood Researchの市場調査報告書です。

Description

KEY FINDINGS
The Global MRI systems market is expected to grow at a CAGR of 3.93% during the forecast period of 2018-2026. The major factors driving the market growth include the rising global geriatric population, technological advancements, increasing awareness among consumers, growing prevalence of chronic diseases and high incidences of accidents and injuries.
MARKET INSIGHTS
The global MRI systems market is segmented on the basis of architecture, field-strength, technology, and applications. The Architecture segment can further be classified into Open MRI systems, Closed MRI systems and extremity/dedicated MRI. The closed MRI systems segment accounted for the highest share of MRI systems market due to benefits such as faster scanning and a high resolution. The Field-Strength is further segmented into Low-to-mid field MRI systems, High field MRI systems, Very high-field MRI systems and Ultra-high-field MRI systems. The Technology segment is further divided into MR Angiogram, MR Venogram, Functional MRI, MRS, gradient echo imaging and other related technologies. The Application segment is further divided into Whole-body MRI, MRI for brain & neurological disorders, spine MRI, head and neck MRI, abdomen and pelvis MRI, etc.

REGIONAL INSIGHTS
Geographically, the global MRI systems market has been segmented into North America, Europe, Asia Pacific and Rest of World.The North America region accounted for the highest share in 2017 due to the growing geriatric population and increasing investments by the government and the healthcare industry. However, it is the Asia-Pacific market which is predicted to be the fastest-growing region for the MRI systems market over the forecast period due to the increasing number of heart, brain or neurology related diseases and rising manufacture outsourcing in the region.
COMPETITIVE INSIGHTS
Some of the major players in the market include Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, and Hitachi Medical Corp .Geographical expansion is the most widely adopted strategy by the major companies in the market. For instance, Japan-based companies Toshiba and Hitachi have set up manufacturing facilities in China to leverage the country's low-cost manufacturing facilities. Hitachi has also set its sight on Europe while other companies such as GE Healthcare and Philips Healthcare are also planning to enter other emerging markets.



目次

Table of Contents

1. RESEARCH SCOPE 1.1. STUDY GOALS 1.2. SCOPE OF THE MARKET STUDY 1.3. WHO WILL FIND THIS REPORT USEFUL? 1.4. STUDY AND FORECASTING YEARS 2. RESEARCH METHODOLOGY 2.1. SOURCES OF DATA 2.1.1. SECONDARY DATA 2.1.2. PRIMARY DATA 2.2. TOP DOWN APPROACH 2.3. BOTTOM-UP APPROACH 2.4. DATA TRIANGULATION 3. EXECUTIVE SUMMARY 3.1. MARKET SUMMARY 3.2. KEY FINDINGS 3.2.1. ALLERGIC CONJUNCTIVITIS IS BECOMING INCREASINGLY PREVALENT 3.2.2. SKIN PRICK TEST IS THE MOST PREVALENT TYPE OF ALLERGY TESTING 3.2.3. ANTIHISTAMINES TREATMENT HOLDS THE LARGEST MARKET SHARE 4. MARKET DETERMINANTS 4.1. MARKET DRIVERS 4.1.1. HIGH INCIDENCES AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES 4.1.2. RISING ENVIRONMENTAL POLLUTION 4.1.3. HIGH USE OF TOBACCO 4.1.4. PRESENCE OF HIGH UNMET MEDICAL NEEDS 4.2. MARKET RESTRAINTS 4.2.1. STRINGENT REGULATIONS FOR MEDICAL DEVICES 4.2.2. LACK OF AWARENESS ABOUT ALLERGIC DISEASES 4.2.3. HIGH CAPITAL REQUIREMENTS 4.2.4. HIGH DEGREE OF CONSOLIDATION ACTS AS AN ENTRY BARRIER FOR NEW ENTRANTS 4.2.5. ADVERSE EFFECTS OF DRUGS 4.3. MARKET OPPORTUNITIES 4.3.1. ASIAN MARKET PRESENTS HIGH-GROWTH OPPORTUNITIES 4.3.2. RISE IN AWARENESS ABOUT ALLERGIC RHINITIS 4.4. MARKET CHALLENGES 4.4.1. ALTERNATE THERAPIES AND DRUGS 4.4.2. EASY AVAILABILITY OF GENERIC DRUGS 4.4.3. INCREASING HEALTHCARE EXPENDITURE 4.4.4. PATENT EXPIRIES AND COMPETITION FROM GENERIC DRUGS 5. MARKET SEGMENTATION 5.1. MARKET BY TREATMENTS, DIAGNOSTICS AND IMMUNOTHERAPY 2018-2026 5.1.1. TREATMENTS 5.1.1.1. TREATMENT MARKET BY AVAILABILITY 5.1.1.1.1. PRESCRIPTION 5.1.1.1.2. OVER THE COUNTER 5.1.1.2. TREATMENT MARKET BY ADMINISTRATION 5.1.1.2.1. ORAL 5.1.1.2.2. SPRAY 5.1.1.2.3. OCULAR 5.1.1.2.4. TOPICAL 5.1.1.3. TREATMENT MARKET BY PRODUCTS 5.1.1.3.1. ANTIHISTAMINES 5.1.1.3.2. SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS 5.1.1.3.3. CORTICOSTEROIDS 5.1.1.3.4. LEUKOTRIENES 5.1.1.3.5. MAST CELL STABILIZERS 5.1.2. DIAGNOSTICS 5.1.2.1. SKIN TESTING 5.1.2.2. ANTIBODY 5.1.3. IMMUNOTHERAPY 5.1.3.1. SUBCUTANEOUS ADMINISTRATION 5.1.3.2. SUBLINGUAL LIQUID SOLUTIONS 5.1.3.3. SUBLINGUAL TABLETS 6. KEY ANALYTICS 6.1. PORTER’S FIVE FORCE ANALYSIS 6.1.1. THREAT OF NEW ENTRANTS 6.1.2. THREAT OF SUBSTITUTES 6.1.3. BARGAINING POWER OF BUYERS 6.1.4. BARGAINING POWER OF SUPPLIERS 6.1.5. THREAT OF RIVALRY 6.2. KEY BUYING CRITERIA 6.3. SUPPLY CHAIN ANALYSIS 6.4. PATENT ANALYSIS 7. GEOGRAPHICAL ANALYSIS 7.1. NORTH AMERICA 7.1.1. THE UNITED STATES 7.1.2. CANADA 7.2. EUROPE 7.2.1. GERMANY 7.2.2. FRANCE 7.2.3. THE UK 7.2.4. RUSSIA 7.2.5. REST OF EUROPE 7.3. ASIA-PACIFIC 7.3.1. INDIA 7.3.2. CHINA 7.3.3. JAPAN 7.3.4. AUSTRALIA AND NEW ZEALAND 7.3.5. REST OF APAC 7.4. REST OF WORLD 7.4.1. MIDDLE EAST AND AFRICA 7.4.2. LATIN AMERICA 8. COMPANY PROFILES 8.1. ALLERGAN PLC 8.1.1. COMPANY OVERVIEW 8.1.2. PRODUCTION PORTFOLIO 8.1.3. SCOT ANALYSIS 8.1.4. STRATEGIC INITIATIVE 8.2. BECKMAN COULTER 8.2.1. COMPANY OVERVIEW 8.2.2. PRODUCT PORTFOLIO 8.2.3. SCOT ANALYSIS 8.2.4. STRATEGIC INITIATIVES 8.3. GLAXOSMITHKLINE PLC 8.3.1. COMPANY OVERVIEW 8.3.2. PRODUCT PORTFOLIO 8.3.3. SCOT ANALYSIS 8.3.4. STRATEGIC INITIATIVES 8.4. HITACHI CHEMICAL DIAGNOSTICS INC. 8.4.1. COMPANY OVERVIEW 8.4.2. PRODUCT PORTFOLIO 8.4.3. SCOT ANALYSIS 8.4.4. STRATEGIC INITIATIVES 8.5. JOHNSON & JOHNSON 8.5.1. COMPANY OVERVIEW 8.5.2. PRODUCT PORTFOLIO 8.5.3. SCOT ANALYSIS 8.5.4. STRATEGIC INITIATIVES 8.6. MERCK 8.6.1. COMPANY OVERVIEW 8.6.2. PRODUCT PORTFOLIO 8.6.3. SCOT ANALYSIS 8.6.4. STRATEGIC MOVES 8.7. PFIZER 8.7.1. COMPANY OVERVIEW 8.7.2. PRODUCT PORTFOLIO 8.7.3. SCOT ANALYSIS 8.7.4. STRATEGIC INITIATIVES 8.8. SANOFI 8.8.1. COMPANY OVERVIEW 8.8.2. PRODUCT PORTFOLIO 8.8.3. SCOT ANALYSIS 8.8.4. STRATEGIC INITIATIVES 8.9. THERMO FISHER DIAGNOSTICS 8.9.1. COMPANY OVERVIEW 8.9.2. PRODUCT PORTFOLIO 8.9.3. SCOT ANALYSIS 8.9.4. STRATEGIC INITIATIVES 8.10. F. HOFFMANN-LA ROCHE LTD 8.10.1. COMPANY OVERVIEW 8.10.2. PRODUCT PORTFOLIO 8.10.3. SCOT ANALYSIS 8.10.4. STRATEGIC INITIATIVES 8.11. MYLAN N.V. 8.11.1. COMPANY OVERVIEW 8.11.2. PRODUCT PORTFOLIO 8.11.3. SCOT ANALYSIS 8.11.4. STRATEGIC INITIATIVES TABLE LIST TABLE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY GEOGRAPHY 2018-2026 ($ MILLION) TABLE 2 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY TREATMENTS, DIAGNOSTICS AND IMMUNOTHERAPY 2018-2026 ($ MILLION) TABLE 3 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY AVAILABILITY 2018-2026 ($ MILLION) TABLE 4 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY ADMINISTRATION 2018-2026 ($ MILLION) TABLE 5 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY PRODUCTS 2018-2026 ($ MILLION) TABLE 6 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN DIAGNOSTICS 2018-2026 ($ MILLION) TABLE 7 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN IMMUNOTHERAPY 2018-2026 ($ MILLION) TABLE 8 NORTH AMERICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) TABLE 9 EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) TABLE 10 ASIA PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) TABLE 11 REST OF THE WORLD ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE LIST FIGURE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 2 GLOBAL TREATMENTS MARKET IN PRESCRIPTION 2018-2026 ($ MILLION) FIGURE 3 GLOBAL TREATMENTS MARKET IN OVER THE COUNTER 2018-2026 ($ MILLION) FIGURE 4 GLOBAL TREATMENTS MARKET IN ORAL 2018-2026 ($ MILLION) FIGURE 5 GLOBAL TREATMENTS MARKET IN SPRAY 2018-2026 ($ MILLION) FIGURE 6 GLOBAL TREATMENTS MARKET IN OCULAR 2018-2026 ($ MILLION) FIGURE 7 GLOBAL TREATMENTS MARKET IN TOPICAL 2018-2026 ($ MILLION) FIGURE 8 GLOBAL TREATMENTS MARKET IN ANTIHISTAMINES 2018-2026 ($ MILLION) FIGURE 9 GLOBAL TREATMENTS MARKET IN SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS 2018-2026 ($ MILLION) FIGURE 10 GLOBAL TREATMENTS MARKET IN CORTICOSTEROIDS 2018-2026 ($ MILLION) FIGURE 11 GLOBAL TREATMENTS MARKET IN LEUKOTRIENES 2018-2026 ($ MILLION) FIGURE 12 GLOBAL TREATMENTS MARKET IN MAST CELL STABILIZERS 2018-2026 ($ MILLION) FIGURE 13 GLOBAL DIAGNOSTICS MARKET IN SKIN TESTING 2018-2026 ($ MILLION) FIGURE 14 GLOBAL TREATMENTS MARKET IN ANTIBODY 2018-2026 ($ MILLION) FIGURE 15 GLOBAL TREATMENTS MARKET IN SUBCUTANEOUS ADMINISTRATION 2018-2026 ($ MILLION) FIGURE 16 GLOBAL TREATMENTS MARKET IN SUBLINGUAL LIQUID SOLUTIONS 2018-2026 ($ MILLION) FIGURE 17 GLOBAL TREATMENTS MARKET IN SUBLINGUAL TABLETS 2018-2026 ($ MILLION) FIGURE 18 KEY BUYING CRITERIA OF ALLERGY DIAGNOSTICS AND TREATMENT MARKET FIGURE 19 THE UNITED STATES ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 20 CANADA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 21 PERCENTAGE OF PEOPLE SUFFERING FROM SEVERE FOOD ALLERGY IN CANADA 2017 FIGURE 22 GERMANY ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 23 FRANCE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 24 THE UNITED KINGDOM ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 25 RUSSIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 26 REST OF EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 27 INDIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 28 CHINA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 29 JAPAN ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 30 AUSTRALIA AND NEW ZEALAND ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 31 REST OF APAC ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 32 MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION) FIGURE 33 LATIN AMERICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

List of Tables

TABLE LIST
TABLE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY TREATMENTS, DIAGNOSTICS AND IMMUNOTHERAPY 2018-2026 ($ MILLION)
TABLE 3 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY AVAILABILITY 2018-2026 ($ MILLION)
TABLE 4 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY ADMINISTRATION 2018-2026 ($ MILLION)
TABLE 5 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 6 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN DIAGNOSTICS 2018-2026 ($ MILLION)
TABLE 7 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN IMMUNOTHERAPY 2018-2026 ($ MILLION)
TABLE 8 NORTH AMERICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
TABLE 9 EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
TABLE 10 ASIA PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
TABLE 11 REST OF THE WORLD ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

List of Figures

FIGURE LIST
FIGURE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 2 GLOBAL TREATMENTS MARKET IN PRESCRIPTION 2018-2026 ($ MILLION)
FIGURE 3 GLOBAL TREATMENTS MARKET IN OVER THE COUNTER 2018-2026 ($ MILLION)
FIGURE 4 GLOBAL TREATMENTS MARKET IN ORAL 2018-2026 ($ MILLION)
FIGURE 5 GLOBAL TREATMENTS MARKET IN SPRAY 2018-2026 ($ MILLION)
FIGURE 6 GLOBAL TREATMENTS MARKET IN OCULAR 2018-2026 ($ MILLION)
FIGURE 7 GLOBAL TREATMENTS MARKET IN TOPICAL 2018-2026 ($ MILLION)
FIGURE 8 GLOBAL TREATMENTS MARKET IN ANTIHISTAMINES 2018-2026 ($ MILLION)
FIGURE 9 GLOBAL TREATMENTS MARKET IN SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS 2018-2026 ($ MILLION)
FIGURE 10 GLOBAL TREATMENTS MARKET IN CORTICOSTEROIDS 2018-2026 ($ MILLION)
FIGURE 11 GLOBAL TREATMENTS MARKET IN LEUKOTRIENES 2018-2026 ($ MILLION)
FIGURE 12 GLOBAL TREATMENTS MARKET IN MAST CELL STABILIZERS 2018-2026 ($ MILLION)
FIGURE 13 GLOBAL DIAGNOSTICS MARKET IN SKIN TESTING 2018-2026 ($ MILLION)
FIGURE 14 GLOBAL TREATMENTS MARKET IN ANTIBODY 2018-2026 ($ MILLION)
FIGURE 15 GLOBAL TREATMENTS MARKET IN SUBCUTANEOUS ADMINISTRATION 2018-2026 ($ MILLION)
FIGURE 16 GLOBAL TREATMENTS MARKET IN SUBLINGUAL LIQUID SOLUTIONS 2018-2026 ($ MILLION)
FIGURE 17 GLOBAL TREATMENTS MARKET IN SUBLINGUAL TABLETS 2018-2026 ($ MILLION)
FIGURE 18 KEY BUYING CRITERIA OF ALLERGY DIAGNOSTICS AND TREATMENT MARKET
FIGURE 19 THE UNITED STATES ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 20 CANADA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 21 PERCENTAGE OF PEOPLE SUFFERING FROM SEVERE FOOD ALLERGY IN CANADA 2017
FIGURE 22 GERMANY ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 23 FRANCE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 24 THE UNITED KINGDOM ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 25 RUSSIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 26 REST OF EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 27 INDIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 28 CHINA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 29 JAPAN ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 30 AUSTRALIA AND NEW ZEALAND ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 31 REST OF APAC ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
FIGURE 33 LATIN AMERICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る